Oryx Pharmaceuticals Inc. Announces Launch of NAPRELAN(TM)

MISSISSAUGA, ON, July 16 /CNW/ - Oryx Pharmaceuticals Inc. (Oryx) is pleased to announce the introduction of prescription NAPRELAN(TM) tablets (naproxen sodium tablets) for the management of the signs and symptoms of osteoarthritis and rheumatoid arthritis.